Filing Analysis

📄 Other SEC Filing Filed Oct 23, 2024
⚪ LOW

Core Laboratories Inc. announced its third quarter 2024 financial results and declared a quarterly cash dividend of $0.01 per share.

📋 Key Facts

  • Announced Q3 2024 financial results on October 23, 2024 (Item 2.02).
  • Declared a quarterly cash dividend of $0.01 per share of common stock (Item 7.01).
  • Record date for the dividend is November 4, 2024.
  • Payment date for the dividend is November 25, 2024.
📄 Other SEC Filing Filed Jul 24, 2024
⚪ LOW

Core Laboratories Inc. announced its second quarter 2024 financial results and declared a quarterly cash dividend of $0.01 per share.

📋 Key Facts

  • Announced Q2 2024 financial results on July 24, 2024.
  • Declared a quarterly cash dividend of $0.01 per share of common stock.
  • Record date for the dividend is August 5, 2024.
  • Payment date for the dividend is August 26, 2024.
📄 Other SEC Filing Filed May 10, 2024
⚪ LOW

Core Laboratories Inc. held its Annual Meeting of Shareholders on May 8, 2024, where shareholders approved all presented proposals. The results included the election of Class III directors and the ratification of KPMG LLP as independent auditors.

🚩 Red Flags

  • None identified in this filing.

📋 Key Facts

  • Annual Meeting held on May 8, 2024, in Houston, Texas.
  • Proposal 1: Election of Lawrence Bruno and Kwaku Temeng to Class III Directors was approved.
  • Proposal 2: Ratification of KPMG LLP as independent registered public accountants for the fiscal year ending Dec 31, 2024, was approved with 40,402,356 votes 'For'.
  • Proposal 3: Advisory vote on executive compensation philosophy and policies was approved.
  • Proposal 4: Amendment and restatement of the 2020 Long-Term Incentive Plan (increasing authorized shares and extending term to May 8, 2034) was approved by a two-thirds majority.
📄 Other SEC Filing Filed Apr 24, 2024
⚪ LOW

Core Laboratories Inc. announced its first quarter 2024 financial results and declared a quarterly cash dividend of $0.01 per share.

📋 Key Facts

  • Announced Q1 2024 financial results on April 24, 2024.
  • Declared a quarterly cash dividend of $0.01 per share of common stock.
  • Record date for the dividend is May 6, 2024.
  • Payment date for the dividend is May 28, 2024.
🚪 Officer Departure Filed Mar 25, 2024
⚪ LOW

Core Laboratories Inc. announced the resignation of its Vice President and Chief Accounting Officer, Kevin Daniels, effective March 21, 2024. The company has appointed Sow Hang Teo, previously the Corporate Controller of Financial Reporting, to succeed him.

🚩 Red Flags

  • None identified; departure is characterized as non-dispute related.

📋 Key Facts

  • Kevin Daniels resigned as VP and Chief Accounting Officer on March 21, 2024, to pursue other opportunities.
  • The departure is explicitly stated not to be due to any dispute or disagreement regarding accounting practices or financial statements.
  • Sow Hang Teo appointed as new VP and Chief Accounting Officer effective March 21, 2024.
  • Mr. Teo has been with the company since February 2006 and was previously the Corporate Controller of Financial Reporting.
📉 Financial Restatement Filed Feb 15, 2024
🟡 MEDIUM

Core Laboratories Inc. filed an amended 8-K to correct unaudited financial information for the quarter and year ended December 31, 2023. The correction stems from a $4.3 million understatement of estimated income tax expense due to a reassessment of foreign tax credits following the company's redomestication from the Netherlands to the United States.

🚩 Red Flags

  • Restatement of previously issued unaudited quarterly results (8-K/A).
  • Significant change in effective tax rate due to redomestication complexities.
  • Revision of key performance metric (ROIC) following the error.

📋 Key Facts

  • Corrected unaudited income tax expense for Q4 2023, which was understated by $4.3 million.
  • Revised Net Income for the full year 2023 from $41,289k to $37,025k.
  • Revised Diluted EPS for the full year 2023 from $0.86 to $0.77.
  • The adjustment resulted in a revision of Return on Invested Capital (ROIC) for Q4 2023 from 13.4% to 12.0%.
  • The error was identified during the preparation of audited financial statements for the Form 10-K.
  • The adjustment did not impact consolidated revenue, operating income, or cash from operations.
📄 Other SEC Filing Filed Jan 31, 2024
⚪ LOW

Core Laboratories Inc. issued an 8-K to announce its fourth quarter and full year 2023 financial results and a quarterly cash dividend declaration.

📋 Key Facts

  • Announced Q4 and FY 2023 financial results on January 31, 2024.
  • Declared a quarterly cash dividend of $0.01 per share of common stock.
  • Dividend record date: February 12, 2024; Payment date: March 4, 2024.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for CLB

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial